2L9
Blueprint Medicines Corp
Biopharmaceutical company developing precision therapies for genomically defined cancers, blood disorders, and inflammatory diseases
CUSIP: 09627Y109HealthcareUS2 holders
Blueprint Medicines Corp
Biopharmaceutical company developing precision therapies for genomically defined cancers, blood disorders, and inflammatory diseases
No financial data available for this security.